00000nam 2200000zi 4500 9.935352 CaOODSP 20240527121639 m o d f cr |n||||||||| 240313e200712 onc o f000 0 eng d CaOODSP eng rda CaOODSP n-cn--- H14-588/2007E-PDF Stakeholder consultation on the proposed regulatory framework for blood and blood components : March-November 2007 : consultation report / Policy and Promotion Division, Centre for Policy and Regulatory Affairs, Biologics and Genetic Therapies Directorate. [Ottawa] : Biologics and Genetic Therapies Directorate, December 2007. 1 online resource (42 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Issued also in French under title: Consultation des intervenants sur le projet de cadre de réglementation du sang et des composants sanguins : mars-novembre 2007 : rapport de consultation. "Health Canada’s blood regulatory framework under the Food and Drugs Act is being revised as one element of a renewed Canadian blood system. This initiative will address the safety of whole blood and blood components in Canada by developing updated and/or new specific regulatory requirements that reflect current technology and practices by referencing commonly accepted safety standards"--Overview, page 4. Blood banks Law and legislation Canada. Blood Transfusion Safety regulations Canada. Canada. Biologics and Genetic Therapies Directorate, issuing body. Canada. Health Canada, issuing body. Consultation des intervenants sur le projet de cadre de réglementation du sang et des composants sanguins : (CaOODSP)9.938684 PDF 217 KB https://publications.gc.ca/collections/collection_2024/sc-hc/H14-588-2007-eng.pdf HTML N/A https://www.canada.ca/en/health-canada/services/drugs-health-products/reports-publications/biologics-radio-pharmaceuticals-genetic-therapies/stakeholder-consultation-proposed-regulatory-framework-blood-blood-components-march-2007-november-2007-consultation-report.html